Introduction
MPs have been extensively used for target binding and concentration since they display high surface area which, when incubated under rotation with a sample, permits to capture the analyte in a more efficient way than employing a two-dimensional sensor surface. CNT incorporation on the electrode surface, on the other hand, increases the electrode roughness and effective area, provides electrocatalytic activity towards a variety of molecules and improves electron transfer. In this work, the combination of the properties of MPs and CNTs is exploited for detection of two analytes of clinical interest, dopamine and MPO. This is performed by first capturing and concentrating the analyte with MPs, then wrapping these MPs with CNTs and finally confining the MP/CNT on the electrode surface for the electrochemical measurement [1] .
Dopamine is a cathecolamine that acts as neurotransmitter and chemical messenger. Abnormal production of dopamine in the brain is associated with a number of neurological and neurodegenerative disorders, such as schizophrenia or Parkinson´s disease. Dopamine is found in urine of healthy individuals at high nM concentrations and is usually detected using sensitive and selective chromatographic methods, such as high performance liquid chromatography (HPLC) and capillary electrophoresis. Those approaches, however, depend on bulky and expensive equipment that has to be handled by specialized staff. Electrochemical sensors have been proposed as a cheaper and simpler alternative for detection of dopamine [2] .
MPO is a cardiovascular biomarker and its monitoring has been defended to be a sensitive predictor of myocardial infarction. Moreover, it has been hypothesized [3] that, in contrast to well established biomarkers like (troponin T, creatine kinase MB isoforms and C-reactive protein), MPO levels identified patients at risk also in the absence of myocardial necrosis. To the best of our knowledge, only a few examples of electrochemical immunosensors have been reported for MPO detection. SWCNT-COOH were resuspended in deionized water (1 mg mL -1 ) and were sonicated in an S15H Elmasonic sonicator at 37 kHz for 1.5 h.
Materials and methods

Chemical reagents, biocomponents and electrodes
Carbon screen printed electrodes (C-SPE) were obtained from DropSens (Oviedo, Spain). They displayed a carbon working electrode (4 mm diameter), a carbon counter electrode and a silver pseudoreference electrode.
Dopamine binding and electrochemical detection by CNT wiring
Incubations and washes were performed at room temperature, protected from light and under rotation (10 rpm). Dopamine was serially diluted in 100 μL of PBS, BSA 0.1%, tween 0.02% (PBS-BT) and each concentration was incubated with 12 μL of MPs (5 mg mL -1 ) for 30 minutes. Here, capture and concentration of dopamine from the sample is based on electrostatic attraction between positively charged dopamine and negatively charged streptavidin-coated MPs at pH=7. After incubation, MPs were washed and resuspended in 10 μL of PBS. For MP/SWCNT magnetic entrapment, MPs were pippeted for 20s with 4 μL of 3 times concentrated PBS and 5 μL of SWCNT-COOH [4] and were layered onto the sensor with the aid of a magnet. Finally, 50 μL of citrate phosphate buffer (pH 4.2) were placed on the C-SPE and cyclic voltammetry was performed for dopamine detection (Fig. 1a) .
Magneto immunoassay and chronoamperometric detection of MPO activity
First, streptavidin-MPs were modified with biotinylated anti-MPO. Then, 6 μL of MP-antiMPOs (5 mg mL -1 ) were incubated with different concentrations of MPO for 15 minutes (Fig. 1b) . After the incubation, the MPs were washed and resuspended in 10 μL of PBS, were mixed with SWCNT as described previously, and MP/SWCNT were magnetically confined on the electrode surface. Finally, signal stabilization was achieved in 50 μL of PBS, which were substituted by TMB substrate for the chronoamperometric measurement. ΔI was calculated by subtracting the current measured after signal stabilization in TMB from the current measured after signal stabilization in PBS. (3 σ), and LOQ of 6.6 nM (10 σ). Compared to direct detection of dopamine in solution, the methodology proposed in this work generated significantly higher signals, especially for the lowest concentrations of dopamine tested for which currents up to 10 times higher were registered (Fig. 2b) . The potential effect of interferents in dopamine detection efficiency was next analyzed. It was observed that, at pH 7, neither AA nor UA interfered with dopamine binding and/or detection. This was presumably due to the different isoelectric points of these molecules: dopamine (pI= 8.87), AA (pI= 5.40) and UA (pI= 4.10), because the surface of the streptavidin modified MPs was negatively charged.
Results and discussion
Dopamine electrochemical detection in the presence of interferents and in urine samples
Finally, the assay was applied to dopamine detection in human urine samples. To this end, different dilutions of the urine samples (1:2, 1:5, 1:10 and 1:20) were spiked with increasing concentrations of dopamine. As it is shown, the proposed detection methodology could be operated in diluted urine samples (Fig. 2b) .
Chronoamperometric measurements of MPO
The detection of MPO is founded on its specific capture from the sample using immunofunctionalized MPs, coupled to chronoamperometric detection of MPO endogenous peroxidase activity employing a ready-to-use TMB/H 2 O 2 enzymatic substrate (Fig. 1b) . Fig. 3a illustrates how the wrapping of MPs with increasing amounts of SWCNT (0-4 μL) generated higher signals and lower LODs up to 3 μL of SWCNT. Increasing the amount of SWCNT further worsened the assay LOD. With the optimized conditions for MPO detection, a linear response of ΔI vs MPO concentration was obtained in the range 0-0.12 μg mL -1 and a polynomial trend was observed for the whole range of concentrations studied (0-4 μg mL -1 ). Signal saturation happened above 4 μg mL -1 concentration (Fig. 3b) . The assay was also performed in 1:10 diluted human serum samples and displayed an LOD of 5.43 ng mL -1 , which is equivalent to 54.3 ng mL -1 in the prediluted serum. In view of these results, the current assay would allow discrimination between healthy individuals, which display concentrations of MPO <90 ng ml -1 , and patients at risk of suffering a cardiovascular event (>350 ng ml -1 ), using cheap and disposable C-SPE and commercially available MP and ready-to-use enzyme substrate. 
Conclusions
The method proposed in this work, which relies on target binding and concentration using MPs coupled to electrochemical detection by SWCNT wiring of the MP surface to the electrode, has been proven for the detection of two analytes of clinical interest: dopamine and MPO. In the case of dopamine, the assay has been applied to dopamine detection in diluted human urine. For MPO detection, the measurements were successfully performed in human serum samples, achieving an LOD low enough to discriminate between healthy individuals and patients at risk of suffering a cardiovascular event.
